Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tentin versus generic dexamphetamine in adults with ADHD
2022-003237-19Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dextroamphetamine in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Quantified behavior test and Pharmacokinetic profile comparison. Started Mar 2023; status: active.
02
Drugs
dextroamphetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2022-003237-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003237-19.